Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Articles

Vol. 2 No. 2 (2011): April – June 2011

3D QSAR - Comparative Molecular Similarity Indices Analysis of 2-Heteroarylquinoline-4-amines as Possible Anti-HIV-1 Agents

DOI
https://doi.org/10.37285/ijddd.2.2.2
Submitted
November 28, 2024
Published
2024-12-08

Abstract

Three dimensional quantitative structure activity relationships (3D-QSAR), based upon Comparative Molecular Similarity Indices Analysis (CoMSIA) and partial least square analysis (PLS) with dipole moment and shape descriptors for thirty seven 2-heteroarylquinolines as anti-HIV-1 agents were investigated. The training set and test set consisted of 30 and 7 heteroarylquinoline-4-amines respectively. The combination of steric, donor and acceptor fields in CoMSIA gave the best results with cross-validated and conventional correlation coefficients of 0.55 and 0.92 respectively. The predictive ability of CoMSIA was determined using a test set of seven quinoline-4-amine derivatives giving predictive correlation coefficients of 0.67. These results provided further understanding of the relationship between the structural features of quinoline-4-amines and its activities, which should be applicable to design and find new potential anti-HIV-1 agents.

References

  1. [1] Gallo, R.C.; Salahuddin, S.Z.; Popovic, M.; Shearer, G.M.; Kaplan, M.; Haynes B.F.; Palker, T.J.; Redfield, R.; Oleske, J.; Safai B. Science. 1984, 224, 500.
  2. [2] Barre, S.F.; Chermann, J.C.; Rey, F.; Nugeyre, M.T.; Chamaret, S.; Gruest, J.; Dauguet, C.; Axler-Blin, C.; Vezinet-Brun, F.; Rouzioux, C.; Rozenbaum, W.; Montagnier, L. Science. 1983, 220, 868.
  3. [3] De Clercq, E. J. Med. Chem. 1995, 38, 2491.
  4. [4] Milton, J.; Slater, M.J.; Bird, A.J.; Spinks, D.; Scott, G.; Price, C.E.; Downing, S.; Green, D.V.S.; Madar, S.; Bethell, R.; Stammers, D.K. Bioorg. Med. Chem. Lett. 1998, 8, 2623.
  5. [5] Molina, A.J.; Arnold, E. Biochemistry. 1991, 30, 6351.
  6. [6] Hopkins, A.L.; Ren, J.S.; Esnouf, R.M.; Willcox, B.E.; Jones, E.Y.; Ross, C.; Miyasaka, T.; Walker, R.T.; Tanaka, H.; Stammers, D.K.; Stuart, D. I. J. Med. Chem. 1996, 39, 1589.
  7. [7] De Clercq, E. The Int. J. Biochem. Cell Biol. 2004, 36, 1800.
  8. [8] Wang, J.M.; Morin, P.; Wang, W.; Kollman, P.A. J Amer. Chem. Soc. 2001, 123, 5221.
  9. [9] De Clercq, E. Antiviral Res. 1998, 38, 153.
  10. [10] Pauwels, R. Current Opin. Pharmacol. 2004, 4, 437.
  11. [11] Young, S.D.; Britcher, S.F.; Tran, L.O.; Payne, L.S.; Lumma, W.C.; Lyle, T.A.; Huff, J.R.; Anderson, P.S.; Olsen, D.B.; Carroll, S. S. Antimicrob. Agents Chemother. 1995, 39, 2602.
  12. [12] Klebe, G.; Abraham, U.; Mietzner, T. J. Med. Chem. 1994, 37, 4130.
  13. [13] Bohm, M.; Sturzebecher, J.; Klebe, G. J. Med. Chem. 1999, 42, 458.
  14. [14] Buolamwini, J. K.; Assefa, H. J. Med. Chem. 2002, 45, 841.
  15. [15] Nair, A.C.; Jayatilleke, P.; Wang, X.; Miertus, S.; Welsh, W.J. J. Med. Chem. 2002, 45, 973.
  16. [16] Pungpo, P.; Hannongbua, S. J. Mol. Graphics Modell. 2000, 18, 581.
  17. [17] Jayatilleke, P.R.N.; Nair, A.C.; Zauhar, R.; Welsh, W.J. J. Med. Chem. 2000, 43, 4446.
  18. [18] Barreca, M.L.; Carotti, A.; Chimirri, A.; Monforte, A.; Pellegrini, C.M.M.; Rao, A. Bioorg. Med. Chem. 1999, 7, 2283.
  19. [19] Hilgeroth, A.; Fleischer, R.; Wiese, M.; Heinemann, F.W.J. Comput. Aided Mol. Design. 1999, 13, 233.
  20. [20] Debnath, A.K. J. Med. Chem. 1999, 42, 249.
  21. [21] Raghavan, K.; Buolamwini, J.K.; Fesen, M.R.; Pommier, Y.; Kohn, K.W.; Weinstein, J.N. J. Med. Chem. 1995, 38, 890.
  22. [22] Oprea, T.I.; Waller, C.L.; Marshall, G.R. Drug Des. Discovery. 1994, 12, 29.
  23. [23] Debnath, A.K.; Jiang, S.; Strick, N.; Lin, K.; Haberfield, P.; Neurath, A.R. J. Med. Chem. 1994, 37, 1099.
  24. [24] Chen, H.F.; Li, Q.; Yao, X.J.; Fan, B.T.; Yuan, S.G.; Panaye, A.; Doucet, J.P. QSAR Comb. Sci. 2003, 22, 604.
  25. [25] Chen, H.F.; Li, Q.; Yao, X.J.; Fan, B.T.; Yuan, S.G.; Panaye, A.; Doucet, J.P. QSAR Comb. Sci. 2004, 23, 36.
  26. [26] Cramer, R.D.; Patterson, D.E.; Bunce, J.D. J. Amer. Chem. Soc. 1988, 110, 5959.
  27. [27] Desiraju, G.R.; Gopalakrishnan, B.; Jetti, R.K.; Nagaraju, A.; Raveendra, J.D.; Sharma, A.; Sobhia, M.E.; Thilagavathy, R. J. Med. Chem. 2002, 45, 4847.
  28. [28] Yang, G.F.; Huang, X.Q. Curr. Pharm. Design. 2006, 12, 4601.
  29. [29] Chakroborti, A.K.; Gopalakrishnan, B.; Sobhia, M.E.; Malde, A.K. Eur. J. Med. Chem. 2003, 38, 975.
  30. [30] Klebe, G.; Abraham, U.J. Comput. Aided Mol. Design. 1999, 13, 1.
  31. [31] Singh, S. K.; Dessalew, N.; Bharatam, P.V. Eur. J. Med. Chem. 2006, 41, 1310.
  32. [32] Strekowski, L.; Mokrosz, M.J.; Honkan, V.A. J. Med. Chem. 1991, 34, 1739.
  33. [33] Kireev, D.B.; Chretein, J.R.; Raevsky, O.A. Eur. J. Med. Chem. 1995, 30, 395.
  34. [34] Tripos inc., Sybyl 7.1; 1699 South Hanley Rd., St. Louis, MO 63144, USA.
  35. [35] Clark, M.; Cramer, R.D.; Van Opdenbosch, N. J. Comp. Chem. 1989, 10, 982.
  36. [36] Gasteiger, J.; Marsilli, M. Tetrahedron. 1980, 36, 3219.
  37. [37] Geladi, P.; Kowalski, B.R. Anal. Chim. Acta. 1986, 186, 1.
  38. [38] Wold, S.; Johansson, A.; Cochi, M.; Kubinyi, H. ESCOM. 1993, Lieden, 523.
  39. [39] Barakat, M.T.; Dean, P.M. J. Comp. Aided Mol. Des. 1990, 4, 295.
  40. [40] Sekhar, Y.N.; Shashinayana, M.R.; Ravikumar, M.; Mahmood, S.K. Chem. Biol. Drug Des. 2007, 70, 511.

Similar Articles

<< < 1 2 3 4 5 

You may also start an advanced similarity search for this article.